Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Actos Bellwether Trials in MDL to Begin January 2014 February 27, 2013 Austin Kirk Add Your Comments As the first Actos trial in the country is being presented to a California state court jury on behalf of a former users of the diabetes drug diagnosed with bladder cancer, the U.S. District Judge presiding over the federal Actos litigation has scheduled the first bellwether trial in the Multidistrict Litigation (MDL) to begin early next year. In a Scheduling Order (PDF) issued on February 19, U.S. District Judge Rebecca Doherty established a new “Pilot Bellwether Program” in the Actos MDL, with a stream-lined trial preparation schedule that is designed to result in a minimum of two trials in the federal court system, with the first beginning on January 27, 2014 and a second beginning on April 14, 2014. Judge Doherty is presiding over pretrial proceedings in all Actos bladder cancer lawsuits filed in U.S. District Courts throughout the country. Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION More than 3,000 complaints have been filed by former users of Actos, and all lawsuits brought in the federal court system are being coordinated during pretrial proceedings before Judge Doherty in the U.S. District Court for the Western District of Louisiana. The consolidated proceedings are designed to reduce duplicative discovery in the cases, eliminate conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts. All of the complaints involves similar allegations that side effects of Actos, which was used by millions of Americans for treatment of type 2 diabetes, increases the risk of bladder cancer when it is used over a long period of time. The lawsuits claim that the drug’s manufacturer, Takeda Pharmaceuticals, failed to provide adequate warnings to consumers or the medical community and ignored information about the link between bladder cancer and Actos before the medication was even introduced. In addition to the federal Actos lawsuits, a number of cases are pending in various state courts throughout the country. Trial is currently underway in California state court involving a lawsuit filed by Jack Cooper, who was diagnosed with bladder cancer after using Actos for more than two years. The case was given an expedited trial date due to Cooper’s grave health. Trial Schedule Considered “Hard and Fast” While the first trials in the federal Actos litigation will begin about a year after Cooper’s trial began, Judge Doherty has established “hard and fast” deadlines to work through the large volume of cases pending in the MDL and prepare for the first trial dates within one year. “This Court is aware that the schedule established herein will place extraordinary burdens on this Court, counsel and the parties,” wrote Judge Doherty in the Scheduling Order. “Nonetheless, this abbreviated schedule is imposed so as to serve the very important goal of moving these proceedings toward completion of this Court’s responsibilities in a reasonable timeframe.” The Actos bellwether trials are designed to serve as test cases that will help the parties gauge how juries are likely to respond to evidence, testimony and arguments that will probably be repeated throughout hundreds of similar claims filed by individuals diagnosed with bladder cancer after using the diabetes drug. In complex pharmaceutical litigation involving a large number of claims over injuries linked to the same medication, the outcome of these early trial dates often help facilitate a resolution to the litigation and may result in agreements to settle Actos lawsuits without presenting each case to a jury. Judge Doherty indicates that the deadlines established in the aggressive schedule will not be extended, continued or delayed unless there is “extraordinarily good cause shown.” To prepare the first bellwether case for trial in federal court, the parties have been directed to each nominate 5 lawsuits for the Pilot Bellwether Discovery pool by April 1, 2013. The only cases that will be eligible for this initial trial pool will be lawsuits filed by Plaintiffs who have actually been diagnosed with bladder cancer after consuming Actos, such that no case will be considered if the Plaintiff only alleges that they have suffered symptoms or fear of developing cancer. To be eligible, Plaintiffs must also submit their Fact Sheet and a complete set of medical records prior to the Defendants by March 8, 2013. Out of the initial pool of 10 bellwether cases, the Plaintiffs will identify their nominee for the first trial date by July 15, 2013 and the Defendants will identify their nominee for the second trial date at the same time. All discovery in the cases is to be completed by October 1, 2013, with a pretrial conference scheduled for January 13, 2014 and the first trial set to begin on January 27th. Tags: Actos, Actos Bladder Cancer, Bladder Cancer, California, Cancer, Diabetes, Diabetes Drug, Takeda Pharmaceuticals Image Credit: | More Actos Lawsuit Stories Actos Bladder Cancer Warnings Updated by FDA to Add New Study Data Reviewed December 13, 2016 Bladder Cancer Risk with Actos Highlighted in a New Study April 5, 2016 Actos Side Effects May Increase Risk of Bone Fractures, Weight Gain: Study March 1, 2016 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)